메뉴 건너뛰기




Volumn 38, Issue 9, 2014, Pages 1165-1171

Changes in body weight and blood pressure: Paradoxical outcome events in overweight and obese subjects with cardiovascular disease

Author keywords

myocardial infarction; outcome events; sibutramine; weight loss

Indexed keywords

PLACEBO; SIBUTRAMINE; ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE;

EID: 84924980263     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.2     Document Type: Article
Times cited : (24)

References (30)
  • 1
    • 27644457743 scopus 로고    scopus 로고
    • Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: A case-control study
    • Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
    • (2005) Lancet , vol.366 , pp. 1640-1649
    • Yusuf, S.1    Hawken, S.2    Ounpuu, S.3    Bautista, L.4    Franzosi, M.G.5    Commerford, P.6
  • 3
    • 0038460302 scopus 로고    scopus 로고
    • The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report
    • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
    • (2003) JAMA , vol.289 , pp. 2560-2572
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3    Cushman, W.C.4    Green, L.A.5    Izzo, Jr.J.L.6
  • 4
    • 35148892823 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice: Executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
    • Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007; 28: 2375-2414.
    • (2007) Eur Heart J , vol.28 , pp. 2375-2414
    • Graham, I.1    Atar, D.2    Borch-Johnsen, K.3    Boysen, G.4    Burell, G.5    Cifkova, R.6
  • 5
    • 15944373229 scopus 로고    scopus 로고
    • Pharmacologic and surgical management of obesity in primary care: A clinical practice guideline from the American College of Physicians
    • Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2005; 142: 525-531.
    • (2005) Ann Intern Med , vol.142 , pp. 525-531
    • Snow, V.1    Barry, P.2    Fitterman, N.3    Qaseem, A.4    Weiss, K.5
  • 6
    • 84863412995 scopus 로고    scopus 로고
    • Maintained intentional weight loss reduces cardiovascular outcomes: Results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
    • Caterson ID, Finer N, Coutinho W, Van Gaal LF, Maggioni AP, Torp-Pedersen C et al. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab 2012; 14: 523-530.
    • (2012) Diabetes Obes Metab , vol.14 , pp. 523-530
    • Caterson, I.D.1    Finer, N.2    Coutinho, W.3    Van Gaal, L.F.4    Maggioni, A.P.5    Torp-Pedersen, C.6
  • 9
    • 33750061909 scopus 로고    scopus 로고
    • ABC of obesity Management: Part II-drugs
    • Lean M, Finer N. ABC of obesity. Management: part II-drugs. BMJ 2006; 333: 794-797.
    • (2006) BMJ , vol.333 , pp. 794-797
    • Lean, M.1    Finer, N.2
  • 10
    • 76249091342 scopus 로고    scopus 로고
    • The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women
    • Halford JC, Boyland EJ, Cooper SJ, Dovey TM, Huda MS, Dourish CT et al. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women. J Psychopharmacol 2010; 24: 99-109.
    • (2010) J Psychopharmacol , vol.24 , pp. 99-109
    • Halford, J.C.1    Boyland, E.J.2    Cooper, S.J.3    Dovey, T.M.4    Huda, M.S.5    Dourish, C.T.6
  • 11
    • 33646195269 scopus 로고    scopus 로고
    • Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects
    • Heusser K, Tank J, Diedrich A, Engeli S, Klaua S, Krüger N et al. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects. Clin Pharmacol Ther 2006; 79: 500-508.
    • (2006) Clin Pharmacol Ther , vol.79 , pp. 500-508
    • Heusser, K.1    Tank, J.2    Diedrich, A.3    Engeli, S.4    Klaua, S.5    Krüger, N.6
  • 12
    • 32244441512 scopus 로고    scopus 로고
    • Neurochemical, neuroautonomic and neuropharmacological acute effects of sibutramine in healthy subjects
    • Lechin F, van der Dijs B, Hernandez G, Orozco B, Rodriguez S, Baez S. Neurochemical, neuroautonomic and neuropharmacological acute effects of sibutramine in healthy subjects. Neurotoxicology 2006; 27: 184-191.
    • (2006) Neurotoxicology , vol.27 , pp. 184-191
    • Lechin, F.1    Van Der Dijs, B.2    Hernandez, G.3    Orozco, B.4    Rodriguez, S.5    Baez, S.6
  • 14
    • 36849095595 scopus 로고    scopus 로고
    • Cardiovascular responses to weight management and sibutramine in high-risk subjects: An analysis from the SCOUT trial
    • Torp-Pedersen C, Caterson I, Coutinho W, Finer N, Van Gaal L, Maggioni A et al. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J 2007; 28: 2915-2923.
    • (2007) Eur Heart J , vol.28 , pp. 2915-2923
    • Torp-Pedersen, C.1    Caterson, I.2    Coutinho, W.3    Finer, N.4    Van Gaal, L.5    Maggioni, A.6
  • 15
    • 27744466523 scopus 로고    scopus 로고
    • The SCOUT study: Risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients
    • James WP. The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients. Eur Heart J Suppl 2005; 7: L44-L48.
    • (2005) Eur Heart J Suppl , vol.7 , pp. L44-L48
    • James, W.P.1
  • 16
    • 59349108818 scopus 로고    scopus 로고
    • Blood pressure changes associated with sibutramine and weight management-an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)
    • Sharma AM, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP et al. Blood pressure changes associated with sibutramine and weight management-an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT). Diabetes Obes Metab 2009; 11: 239-250.
    • (2009) Diabetes Obes Metab , vol.11 , pp. 239-250
    • Sharma, A.M.1    Caterson, I.D.2    Coutinho, W.3    Finer, N.4    Van Gaal, L.5    Maggioni, A.P.6
  • 17
    • 0035793139 scopus 로고    scopus 로고
    • Long-term weight loss and changes in blood pressure: Results of the Trials of Hypertension Prevention, phase II
    • Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134: 1-11.
    • (2001) Ann Intern Med , vol.134 , pp. 1-11
    • Stevens, V.J.1    Obarzanek, E.2    Cook, N.R.3    Lee, I.M.4    Appel, L.J.5    Smith West, D.6
  • 18
    • 0019424146 scopus 로고
    • The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients
    • Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930-933.
    • (1981) N Engl J Med , vol.304 , pp. 930-933
    • Tuck, M.L.1    Sowers, J.2    Dornfeld, L.3    Kledzik, G.4    Maxwell, M.5
  • 21
    • 67651096062 scopus 로고    scopus 로고
    • Explaining the obesity paradox: Cardiovascular risk, weight change, and mortality during long-term follow-up in men
    • Strandberg TE, Strandberg AY, Salomaa VV, Pitkälä KH, Tilvis RS, Sirola J et al. Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men. Eur Heart J 2009; 30: 1720-1727.
    • (2009) Eur Heart J , vol.30 , pp. 1720-1727
    • Strandberg, T.E.1    Strandberg, A.Y.2    Salomaa, V.V.3    Pitkälä, K.H.4    Tilvis, R.S.5    Sirola, J.6
  • 22
    • 84873371097 scopus 로고    scopus 로고
    • Evidence for obesity paradox in patients with acute coronary syndromes: A report from the Swedish Coronary Angiography and Angioplasty Registry
    • Angerås O, Albertsson P, Karason K, Råmunddal T, Matejka G, James S et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 2013; 34: 345-353.
    • (2013) Eur Heart J , vol.34 , pp. 345-353
    • Angerås, O.1    Albertsson, P.2    Karason, K.3    Råmunddal, T.4    Matejka, G.5    James, S.6
  • 23
    • 70449512958 scopus 로고    scopus 로고
    • The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: A report from APPROACH
    • Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J 2009; 30: 2584-2592.
    • (2009) Eur Heart J , vol.30 , pp. 2584-2592
    • Oreopoulos, A.1    McAlister, F.A.2    Kalantar-Zadeh, K.3    Padwal, R.4    Ezekowitz, J.A.5    Sharma, A.M.6
  • 25
    • 77954374543 scopus 로고    scopus 로고
    • Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease
    • Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304: 61-68.
    • (2010) JAMA , vol.304 , pp. 61-68
    • Cooper-Dehoff, R.M.1    Gong, Y.2    Handberg, E.M.3    Bavry, A.A.4    Denardo, S.J.5    Bakris, G.L.6
  • 26
    • 78651485079 scopus 로고    scopus 로고
    • Blood pressure lowering in patients with diabetes-one level might not fit all
    • Cooper-DeHoff RM, Egelund EF, Pepine CJ. Blood pressure lowering in patients with diabetes-one level might not fit all. Nat Rev Cardiol 2011; 8: 42-49.
    • (2011) Nat Rev Cardiol , vol.8 , pp. 42-49
    • Cooper-Dehoff, R.M.1    Egelund, E.F.2    Pepine, C.J.3
  • 27
    • 21344457463 scopus 로고    scopus 로고
    • Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients-sibutramine and blood pressure
    • Birkenfeld AL, Schroeder C, Pischon T, Tank J, Luft FC, Sharma AM et al. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients-sibutramine and blood pressure. Clin Auto Res 2005; 15: 200-206.
    • (2005) Clin Auto Res , vol.15 , pp. 200-206
    • Birkenfeld, A.L.1    Schroeder, C.2    Pischon, T.3    Tank, J.4    Luft, F.C.5    Sharma, A.M.6
  • 28
    • 3242738609 scopus 로고    scopus 로고
    • A likely explanation for the J-curve of blood pressure cardiovascular risk
    • Kannel WB, Wilson PW, Nam BH, D'Agostino RB, Li J. A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol 2004; 94: 380-384.
    • (2004) Am J Cardiol , vol.94 , pp. 380-384
    • Kannel, W.B.1    Wilson, P.W.2    Nam, B.H.3    D'Agostino, R.B.4    Li, J.5
  • 29
    • 33745295923 scopus 로고    scopus 로고
    • Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
    • Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Ann Internal Med 2006; 144: 884-893.
    • (2006) Ann Internal Med , vol.144 , pp. 884-893
    • Messerli, F.H.1    Mancia, G.2    Conti, C.R.3    Hewkin, A.C.4    Kupfer, S.5    Champion, A.6
  • 30
    • 70350440515 scopus 로고    scopus 로고
    • The J-curve between blood pressure and coronary artery disease or essential hypertension: Exactly how essential?
    • Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol 2009; 54: 1827-1834.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1827-1834
    • Messerli, F.H.1    Panjrath, G.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.